SynthesisJAMA cardiology2021

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.

Darren K McGuire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.